DUBLIN, September 6, 2017 /PRNewswire/ --
The "Global Cardiac Pacemakers Market 2017-2021" report has been added to Research and Markets' offering.
The global cardiac pacemakers market is forecast to grow at a CAGR of 12.90% during the period 2017-2021.
The report, Global Cardiac Pacemakers Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
One trend in the market is focus on new product launches. Development of new technologies in pacemakers by the leading manufacturers has positively impacted the output of the device. For instance, Medtronic developed leadless pacemaker, which was approved by the US FDA, is a revolutionary breakthrough in the pacemakers technology as leads were extensively used as a component of pacemaker over the several years.
According to the report, one driver in the market is decline in the prices of pacemakers. Medical device industry has been a profitable market for the manufacturers over the years as the cost of healthcare services are increasing drastically by every passing year. For instance, the US healthcare cost is increasing at a very high speed. However, the prices of medical devices like pacemakers have been dropping. The global cardiac pacemakers market is experiencing intense competition among the key manufacturers and local/regional players. The market is dominated by prominent players like Medtronic, St. Jude Medical, and Boston Scientific; however, the market is open for local players to hold larger share in the global market through breakthrough innovations.
Further, the report states that one challenge in the market is high competition from substitutes. There is an intensive competition from substitutes like medications, cardiac catheter ablation, and ICD. The ICD device is used when the heart muscle is weakened, and fast heartbeat interrupts individual's health condition negatively. Cardiac catheter ablation is performed using radiofrequency (which uses heat energy) or cryoablation (which uses cold temperature). It is implemented depending on the type of abnormal heart rhythm. The medications like antiarrhythmic drugs are used to treat abnormal heartbeat caused due to the irregular electrical activity of the heart.
- Boston Scientific
Other prominent vendors
- Cardiac Science (a subsidiary of Quinton Cardiology)
- CCC Medical Devices
- Cook Medical
- GE Healthcare (a subsidiary of General Electric Company
Key Topics Covered:
Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Research Methodology
Part 04: Introduction
Part 05: Market Landscape
Part 06: Market Segmentation By Product
Part 07: Market Segmentation By Technology
Part 08: Market Segmentation By End-Users
Part 09: Geographical Segmentation
Part 10: Decision Framework
Part 11: Drivers And Challenges
Part 12: Market Trends
Part 13: Vendor Landscape
Part 14: Key Vendor Analysis
Part 15: Appendix
For more information about this report visit https://www.researchandmarkets.com/research/trdr3s/global_cardiac
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets